Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

(2010) Shervin Assassi et al.   ARTHRITIS RESEARCH & THERAPY

Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo

(2009) Jonathan Goldin et al.   CHEST

Classification of Parenchymal Abnormality in Scleroderma Lung Using a Novel Approach to Denoise Images Collected via a Multicenter Study

(2008) Hyun J. Kim et al.   ACADEMIC RADIOLOGY

Interstitial Lung Disease in Systemic Sclerosis

(2008) Nicole S. L. Goh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

(2008) Jonathan G. Goldin et al.   CHEST

Scleroderma lung disease: evolving understanding in light of newer studies

(2008) KM Antoniou et al.   CURRENT OPINION IN RHEUMATOLOGY

Oral Cyclophosphamide for Active Scleroderma Lung Disease: A Decision Analysis

(2008) Dinesh Khanna et al.   MEDICAL DECISION MAKING

Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register

(2008) L. G. Hanitsch et al.   RHEUMATOLOGY

Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies

(2008) Carlotta Nannini et al.   ARTHRITIS RESEARCH & THERAPY

Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease

(2007) Charlie Strange et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE